Greenland Mines Ltd (NASDAQ: GRML) has announced a series of corporate milestones as it transitions into a focused rare earths and critical minerals company, including plans to spin off its biotechnology division in the fourth quarter of 2026. The company also received formal approval from Nasdaq for its application relating to the March 2026 transaction, resolving prior deficiencies and bringing it into full compliance with listing requirements.
The company completed its acquisition of the Sarfartoq project on Sept. 1 following approval by the Government of Greenland. An independent S-K 1300 Initial Assessment for the ST1 deposit estimated a high-case pre-tax net present value of approximately $2.05 billion and a pre-tax internal rate of return of 118.6%. Greenland Mines said planned annual neodymium-praseodymium oxide production from ST1 would equal approximately 34% of current NdPr oxide refining outside China based on 2025 consumption levels during each of the project's nine scheduled operating years.
The company is also reshaping its board, with Riad El-Dada and Dr. Shalom Hirschman stepping down and capital markets veteran Jason Hawkins joining as Greenland Mines advances Sarfartoq and its Skaergaard palladium-gold-platinum project. For more details, visit https://ibn.fm/QN1U9.
This strategic pivot underscores the growing importance of rare earth elements and critical minerals in global supply chains, particularly as nations seek to reduce dependence on Chinese processing. The Sarfartoq project's substantial NdPr output could position Greenland Mines as a significant Western supplier, potentially impacting the clean energy and technology sectors that rely on these materials.
Greenland Mines' dual focus on mining and biotech has been a distinguishing feature, but the planned spin-off signals a clear strategic direction. By separating its biotech division, the company aims to unlock shareholder value and allow each entity to pursue its specific growth strategies. The biotech division, including Klotho's KLTO-202 primary indication for ALS, will become an independent entity, while Greenland Mines will concentrate on its mining assets.
The acquisition of Sarfartoq and the positive initial assessment highlight the project's economic viability. With a high-case NPV of $2.05 billion and an IRR of 118.6%, the project offers substantial potential returns. These figures are based on the ST1 deposit alone, and further exploration could enhance the project's value. The company's vision of a North Atlantic Critical Metals Corridor linking Greenland resources with allied downstream jurisdictions is an ambitious plan that could reshape the critical minerals landscape.
Jason Hawkins' appointment to the board brings capital markets expertise that will be valuable as the company navigates its transition and potential future financing needs. His background in resource capital markets is expected to support Greenland Mines in communicating its story to investors and securing the necessary funding for project development.
Investors and industry observers will be watching closely as Greenland Mines executes its strategy. The spin-off and project developments are subject to regulatory approvals and market conditions. The company's ability to deliver on its milestones will be crucial in maintaining investor confidence and achieving its long-term objectives.
